8-K ·Filed Jun 17, 2026

VTGN

Vistagen Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001628280-26-043989
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine board refresh — no immediate trading signal. Monitor for any subsequent board composition changes or strategic shifts, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VTGN ▼ -63.71% at T+60d
NEUTRAL call ✗ call lost -63.71% · α vs SPY -65.61% · entry $0.6702 → $0.2432
Entry anchored
Jun 17, 03:59 PM ET
via exchange tick
T+1d
-4.52%
call -4.52% · α -4.21%
$0.6399
settled 4mo ago
T+5d
-8.00%
call -8.00% · α -6.33%
$0.6166
settled 3mo ago
T+20d
-64.19%
call -64.19% · α -64.72%
$0.2400
settled 3mo ago
T+60d
-63.71%
call -63.71% · α -65.61%
$0.2432
settled 18d ago

Price Chart

Loading chart...

Executive Summary

Two board members, Margaret FitzPatrick and Dr. Joanne Curley, notified Vistagen they will not stand for re-election at the 2026 Annual Meeting. Both will continue serving until the end of their terms. This is a routine board transition with no C-suite departures or red flags.

Key Facts

  • Margaret FitzPatrick notified on June 16, 2026 of decision not to stand for re-election.
  • Dr. Joanne Curley notified on June 17, 2026 of decision not to stand for re-election.
  • Both will continue as directors until the end of their terms at the 2026 Annual Meeting.
  • No replacements named; no CEO/CFO departure or resignation language.

Financial Impact

No financial impact disclosed.

Risk Factors

  • Potential loss of board expertise if replacements are not equally qualified.
  • Minimal — no material risk to operations or strategy.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (10 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-043989
Document: 0001628280-26-043989-index-headers.html0001628280-26-043989
Document: 0001628280-26-043989-index.html0001628280-26-043989
Document: 0001628280-26-043989.txt0001628280-26-043989
12 reports for VTGN
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +20.40%Jun 11, 2026
Filters
Rows
Reports for VTGN — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
8-K
BEARISH ★ 6/10
$0.2676 $0.2432▲ +9.12%▲ +7.13%$0.2847 (−6.39%)
Aug 14, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$0.2676 $0.2432▼ −9.12%▼ −7.13%$0.2847 (+6.39%)
Jul 31, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$0.2410 $0.2529▲ +4.94%▲ +1.95%$0.2847 (+18.13%)
Jun 30, 2026
13w ago
8-K
BEARISH ★ 7/10
$0.2260 $0.2302▼ −1.86%▼ −2.89%$0.2847 (−25.97%)
Jun 17, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$0.6702 $0.2400▼ −64.19%▼ −64.72%$0.2847 (−57.52%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$0.6900 $0.2461▼ −64.33%▼ −64.53%$0.2847 (−58.74%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 5/10
$0.5731 $0.2492▼ −56.52%▼ −58.41%$0.2847 (−50.32%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 4/10
$0.5351 $0.2492▼ −53.43%▼ −57.05%$0.2847 (−46.79%)
May 19, 2026
19w ago
8-K
NEUTRAL ★ 4/10
$0.6400 $0.6702▲ +4.72%▲ +3.98%$0.2847 (−55.52%)
May 12, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$0.6200 $0.5400▼ −12.90%▼ −11.18%$0.2847 (−54.08%)
Showing 10 of 12

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access